Metabolomics in Autoimmune Diseases: Focus on Rheumatoid Arthritis, Systemic Lupus Erythematous, and Multiple Sclerosis

The metabolomics approach represents the last downstream phenotype and is widely used in clinical studies and drug discovery. In this paper, we outline recent advances in the metabolomics research of autoimmune diseases (ADs) such as rheumatoid arthritis (RA), multiple sclerosis (MuS), and systemic...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoon, Naeun, Jang, Ah-Kyung, Seo, Yerim, Jung, Byung Hwa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708401/
https://www.ncbi.nlm.nih.gov/pubmed/34940570
http://dx.doi.org/10.3390/metabo11120812

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708401/
https://www.ncbi.nlm.nih.gov/pubmed/34940570
http://dx.doi.org/10.3390/metabo11120812

Ejemplares similares